A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Clinical trial NCT06226545 · COMPLETED

Trial details

NCT number: NCT06226545
Sponsor: Lassen Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thyroid Eye Disease Graves Ophthalmopathy Graves Orbitopathy Thyroid Associated Ophthalmopathy Endocrine System Diseases Orbital Diseases Proptosis Eye Diseases

Start date: 2024-03-05
Primary completion: 2025-04-22
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.